Publications & Posters
Scholarly publications
Facioscapulohumeral Muscular Dystrophy
Apitegromab
June 2026
2026 International Research Congress on FSHD
Trial design for the Phase 2 FORGE study evaluating apitegromab in adults with facioscapulohumeral muscular dystrophy
Spinal Muscular Atrophy
Apitegromab
June 2026
2026 Annual SMA Research and Clinical Care Meeting
Assessing the impact of ‘any point differences’ or ‘stability’ in the Hammersmith Functional Motor Scale-Expanded on the independence of patients with SMA
Cardiometabolic Disease
May 2026
The Essential Protein & Antibody Engineering Summit
Design and Evaluation of a Dual Mechanism GLP-1R Agonist Antibody Fusion for Weight Loss with Lean Mass Preservation
Spinal Muscular Atrophy
Apitegromab
March 2026
SMA Europe 2026
Understanding physical therapist perspectives on the clinical meaningfulness of ‘any point differences’ on the Hammersmith Functional Motor Scale-Expanded in SMA
Spinal Muscular Atrophy
Apitegromab
March 2026
SMA Europe 2026
Understanding neurologist perspectives on the clinical meaningfulness of ‘any point differences’ on the Hammersmith Functional Motor Scale-Expanded in SMA
Facioscapulohumeral Muscular Dystrophy
Apitegromab
March 2026
Muscular Dystrophy Association Clinical & Scientific Conference 2026
